Project Grant HT94252510117
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$489K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This federal Project Grant award of $509,979.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports biomedical research initiatives at the University of North Carolina at Chapel Hill (UNC-CH) to develop potentiated chip variants as therapeutics to alleviate tau pathology and neurodegeneration. The award, with a performance period from July 1, 2025 to June 30, 2028, will fund innovative research projects aimed at transforming...
This $1,100,633 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports cancer research and translational science initiatives at the University of North Carolina at Chapel Hill (UNC-CH). Specifically, the award will fund innovative biomedical research projects focused on transforming healthcare for military service members and the broader public. Research areas may include disease prevention, diagnosis, treatment, and...
The University of North Carolina at Chapel Hill received a $1,555,000 Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will fund a 3-year research project to measure the autonomic nervous system responses of warfighters following exertion and resting stressors. This research aims to advance understanding of how the autonomic nervous system is impacted by physical and psychological stressors...
The federal Project Grant award of $860,998.00 was issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from April 1, 2025 to March 31, 2028, supports neurophysiology research focused on understanding the epileptogenesis signals and biomarkers underlying post-traumatic epilepsy. This research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
The Department of the Army Medical Command awarded a $1,000,000 project grant to Duke University's Office of Research Administration Division under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024 and running through May 31, 2027, will fund a practical multi-domain risk model of Alzheimer's disease and related dementias for veteran and non-veteran older U.S. adults. The research project aims to improve the health and care of military service...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $2,826,619.00 to the University of North Carolina at Chapel Hill (UNC-CH) for the research and development of a sublingual formulation of dexmedetomidine to prevent and reduce the incidence of acute stress reactions, autism spectrum disorder, and post-traumatic stress disorder in order to sustain warfighter performance. The award has a performance...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
This federal Project Grant award for $659,922, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a gene therapy research project at Macquarie University in Australia. The project aims to develop a gene therapy approach for nuclear TDP-43 supplementation as a potential pathway to delaying the onset of neurodegenerative diseases. The two-year award, spanning September 2025 to September 2027, will fund sophisticated research...
The University of North Carolina at Chapel Hill will use a $777,500 Project Grant from the Defense Health Agency to support research aimed at reducing expression of TDP-43 protein in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The grant was awarded on April 15, 2023 under the Military Medical Research and Development program (CFDA 12.420). Through April 14, 2025, UNC-Chapel Hill researchers will investigate medical solutions for ALS at the project site in Chapel...
This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...